Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine”

309 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 309 results

Large-scale testing (Phase 3)WithdrawnNCT02100618
What this trial is testing

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Testing effectiveness (Phase 2)Looking for participantsNCT06157151
What this trial is testing

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical CancerHPV-Related CarcinomaHPV-Related Malignancy+2 more
Precigen, Inc 24
Large-scale testing (Phase 3)Study completedNCT01047345
What this trial is testing

V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Who this might be right for
Cervical CancersVulvar CancersVaginal Cancers+1 more
Merck Sharp & Dohme LLC 924
Testing effectiveness (Phase 2)Study completedNCT00359619
What this trial is testing

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 383
Not applicableStudy completedNCT01077856
What this trial is testing

GARDASIL™ Vaccine Impact in Population Study (V501-033)

Who this might be right for
Human Papillomavirus Infections
Merck Sharp & Dohme LLC 54,516
Large-scale testing (Phase 3)Active Not RecruitingNCT04537156
What this trial is testing

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerCondylomata Acuminata
Xiamen University 9,327
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Large-scale testing (Phase 3)Study completedNCT00380367
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 110
Testing effectiveness (Phase 2)Study completedNCT00316693
What this trial is testing

Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,046
Not applicableUnknownNCT03604393
What this trial is testing

Increasing HPV Immunization Rates: The Rural Adolescent Vaccine Enterprise

Who this might be right for
Human Papilloma Virus
Oregon Health and Science University 22,000
Post-approval studies (Phase 4)Looking for participantsNCT05495906
What this trial is testing

Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

Who this might be right for
HPVHuman Papilloma VirusHuman Immunodeficiency Virus
University of British Columbia 275
Not applicableEnded earlyNCT02503111
What this trial is testing

The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men

Who this might be right for
Anal DysplasiaHuman PapillomavirusAnal Cancer
University Health Network, Toronto 71
Testing effectiveness (Phase 2)Study completedNCT00091130
What this trial is testing

SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells

Who this might be right for
Atypical Squamous Cells of Undetermined SignificanceCervical CancerHigh-grade Squamous Intraepithelial Lesion+1 more
National Cancer Institute (NCI) 139
Large-scale testing (Phase 3)Study completedNCT01461096
What this trial is testing

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 575
Testing effectiveness (Phase 2)Study completedNCT00339040
What this trial is testing

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 130
Large-scale testing (Phase 3)Study completedNCT00169494
What this trial is testing

Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 770
Not applicableStudy completedNCT04711265
What this trial is testing

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

Who this might be right for
HPV VaccineHPV InfectionHIV-1-infection
Kenya Medical Research Institute 176
Post-approval studies (Phase 4)Study completedNCT03943875
What this trial is testing

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

Who this might be right for
ImmunizationEfficacyHuman Papilloma Virus
The University of Texas Medical Branch, Galveston 767
Not applicableUnknownNCT05536674
What this trial is testing

SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia

Who this might be right for
HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine
The Behavioural Insights Team 55,176
Large-scale testing (Phase 3)Study completedNCT00578227
What this trial is testing

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 814
Load More Results